Filing metadata

Accession number
0001562180-22-002161
Form type
Form 4
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Mar 02, 2022
Reporting period
Feb 28, 2022
Description
Insider transaction

Explore SEC Filings Hub